Based on the observation that DY-635 uptake is OATP1B3-dependent, it was further investigated whether the covalent linkage of DY-635 to PLGA nanoparticles leads to improved nanoparticle uptake in CML cells. Here, SLCO1B3 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.